Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
| Cat.No. | Product Name | Price |
|---|---|---|
| CSC-DC003175 | Panoply™ Human CIDEB Knockdown Stable Cell Line | Inquiry |
| CSC-SC003175 | Panoply™ Human CIDEB Over-expressing Stable Cell Line | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| AD03758Z | Human CIDEB adenoviral particles | Inquiry |
| LV09060L | human CIDEB (NM_014430) lentivirus particles | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| SHH264065 | shRNA set against Mouse CIDEB (NM_009894.3) | Inquiry |
| SHG169567 | shRNA set against Mouse Cideb(NM_009894.3) | Inquiry |
| SHG169765 | shRNA set against Human CIDEB(NM_014430.2) | Inquiry |
| SHH264069 | shRNA set against Rat CIDEB (NM_001108869.1) | Inquiry |
| SHH275101 | shRNA set against Mouse Dcdc2a (NM_177577.3) | Inquiry |
| SHW014033 | shRNA set against Danio rerio CIDEB (NM_001256257) | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| CDCS413629 | Human CIDEB ORF Clone (BC035970) | Inquiry |
| CDFH003702 | Human CIDEB cDNA Clone(NM_014430.2) | Inquiry |
| CDFR008437 | Rat Cideb cDNA Clone(NM_001108869.1) | Inquiry |
| MiUTR1H-02166 | CIDEB miRNA 3'UTR clone | Inquiry |
| MiUTR1M-03047 | CIDEB miRNA 3'UTR clone | Inquiry |
| MiUTR1M-03710 | DCDC2A miRNA 3'UTR clone | Inquiry |
| CDCB175508 | Danio rerio CIDEB ORF Clone (NM_001256257) | Inquiry |
| CDCB187641 | Rabbit CIDEB ORF clone (XM_002717920.2) | Inquiry |
| CDCR053848 | Mouse Dcdc2a ORF clone (NM_177577.3) | Inquiry |
| CDCR243464 | Mouse Dcdc2a ORF Clone(NM_001195617.1) | Inquiry |
| CDCR297563 | Human CIDEB ORF Clone(NM_014430.2) | Inquiry |
| CDCR375492 | Rat Cideb ORF Clone(NM_001108869.1) | Inquiry |
Doublecortin domain containing 2a (DCDC2a) is a highly conserved protein that belongs to the doublecortin (DCX) family of proteins. The DCX family is characterized by the presence of a conserved doublecortin domain, which is involved in various cellular processes such as cell migration, axon guidance, and synaptic plasticity. DCDC2a is particularly known for its role in neuronal development and migration, making it an important molecule in the field of neuroscience.
The DCDC2a protein is composed of a series of structural domains that give it its unique functional properties. The primary structure of DCDC2a consists of a conserved N-terminal doublecortin domain (DC domain), a variable central region, and a highly conserved C-terminal region. The DC domain is the most conserved region of the protein and is responsible for its interaction with other cellular proteins. The central region contains several functional domains, including a leucine-rich repeat (LRR) domain, a coiled-coil domain, and a cysteine-rich domain. The C-terminal region is responsible for the interaction of DCDC2a with microtubules, which is crucial for its role in neuronal migration.
DCDC2a is involved in several cellular processes, including neuronal development, migration, and synaptic plasticity. In the developing nervous system, DCDC2a is expressed in migrating neurons and plays a critical role in guiding these neurons to their appropriate targets. DCDC2a interacts with other cellular proteins, such as microtubules and actin filaments, to regulate neuronal migration. Moreover, it has been shown that DCDC2a is involved in the regulation of axon guidance and synaptic plasticity, making it a key molecule in neural circuit formation and function.
DCDC2a is a highly conserved protein that plays a crucial role in neuronal development and function. It is involved in various cellular processes, including neuronal migration, axon guidance, and synaptic plasticity. DCDC2a has also been implicated in various neurological disorders, such as autism spectrum disorder (ASD), schizophrenia, and epilepsy. These disorders are characterized by abnormalities in neural development and function, and studies have shown that mutations in the DCDC2a gene can lead to these neurological conditions. For example, mutations in the DCDC2a gene have been identified in patients with ASD, and these mutations are associated with altered neuronal migration and synaptic plasticity.
DCDC2a has become a target for therapeutic intervention in these conditions.Recent studies have provided new insights into the role of DCDC2a in various cellular processes and neurological disorders. For example, researchers have identified new roles for DCDC2a in axon guidance and synaptic plasticity, as well as the mechanisms by which it regulates these processes.
References: